Literature DB >> 2517313

[Aluminum toxicity].

H V Henning1.   

Abstract

In view of the increasing pollution of our environment and forest decline, growing interest has been focused on aluminum toxicity. Aluminum is one of the most abundant metals and commonly present in tap water, beverages, food, cosmetics, and pharmaceutical preparations. Thus everybody is exposed to aluminum to a greater or lesser extent. It is now beyond any doubt that aluminum intoxication may cause encephalopathy, fracturing vitamin D resistant osteomalacia, and microcytic anemia in patients with chronic renal insufficiency as well as in experimental animals. The risk of aluminum intoxication has also to be considered in several other groups. These include elderly individuals with physiologically impaired excretory renal function who are treated with aluminum-containing antacids, patients with chronic liver disease, infants who are fed highly aluminum-contaminated formula at a time when their excretory renal function has not jet fully developed, patients on total parenteral nutrition, and, possibly, patients with Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2517313     DOI: 10.1007/bf01745293

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  83 in total

1.  Syndrome of dyspraxia and multifocal seizures associated with chronic hemodialysis.

Authors:  A C Alfrey; J M Mishell; J Burks; S R Contiguglia; H Rudolph; E Lewin; J H Holmes
Journal:  Trans Am Soc Artif Intern Organs       Date:  1972

2.  Infant formula as a cause of aluminium toxicity in neonatal uraemia.

Authors:  M Freundlich; G Zilleruelo; C Abitbol; J Strauss; M C Faugere; H H Malluche
Journal:  Lancet       Date:  1985-09-07       Impact factor: 79.321

3.  [The effect of 4 different antacids on the gastrointestinal tract and mineral metabolism].

Authors:  F Matzkies; M Köhler; B Webs
Journal:  Fortschr Med       Date:  1984-06-28

4.  Intranuclear aluminum content in Alzheimer's disease, dialysis encephalopathy, and experimental aluminum encephalopathy.

Authors:  D R Crapper; S Quittkat; S S Krishnan; A J Dalton; U De Boni
Journal:  Acta Neuropathol       Date:  1980       Impact factor: 17.088

5.  Bone marrow aluminium storage in renal failure.

Authors:  M Kaye
Journal:  J Clin Pathol       Date:  1983-11       Impact factor: 3.411

6.  Dementia, renal failure, and brain aluminum.

Authors:  A I Arieff; J D Cooper; D Armstrong; V C Lazarowitz
Journal:  Ann Intern Med       Date:  1979-05       Impact factor: 25.391

Review 7.  Aluminum and renal osteodystrophy.

Authors:  D J Sherrard
Journal:  Semin Nephrol       Date:  1986-12       Impact factor: 5.299

8.  Aluminum-related bone disease in mild and advanced renal failure: evidence for high prevalence and morbidity and studies on etiology and diagnosis.

Authors:  A J Smith; M C Faugère; K Abreo; P Fanti; B Julian; H H Malluche
Journal:  Am J Nephrol       Date:  1986       Impact factor: 3.754

9.  Aluminum is associated with low bone formation in patients receiving chronic parenteral nutrition.

Authors:  S M Ott; N A Maloney; G L Klein; A C Alfrey; M E Ament; J W Coburn; D J Sherrard
Journal:  Ann Intern Med       Date:  1983-06       Impact factor: 25.391

10.  Multifactorial low remodeling bone disease during cyclic total parenteral nutrition.

Authors:  M C de Vernejoul; B Messing; D Modrowski; J Bielakoff; A Buisine; L Miravet
Journal:  J Clin Endocrinol Metab       Date:  1985-01       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.